WallStSmart
CRBP

Corbus Pharmaceuticals Holding

NASDAQ: CRBP · HEALTHCARE · BIOTECHNOLOGY

$9.82
+0.00% today

Updated 2026-04-29

Market cap
$178.43M
P/E ratio
P/S ratio
169.88x
EPS (TTM)
$-5.90
Dividend yield
52W range
$6 – $21
Volume
0.2M

Corbus Pharmaceuticals Holding (CRBP) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-18.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-60.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+15.8%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+25.3%
2026-03-09
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-09$-1.25+20.7%$8.01$10.04+25.3%
2025-11-12$-1.90-48.4%$10.42$11.07+6.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.58$-1.25+20.7%
2025-09-30$-1.28$-1.90-48.4%
2025-06-30$-1.23$-1.44-17.1%
2025-03-31$-1.07$-1.39-29.7%
2024-12-31$-1.26$-0.78+38.0%$703376.00-47.9%
2024-09-30$-0.95$-1.15-21.1%
2024-06-30$-1.19$-0.90+24.4%
2024-03-31$-1.09$-0.83+23.9%
2023-12-31$-2.36$-1.81+23.3%$1.35M
2023-09-30$-2.06$-2.05+0.5%
2023-06-30$-3.10$-2.05+33.9%
2023-03-31$-4.09$-4.24-3.7%

Frequently asked questions

Has Corbus Pharmaceuticals Holding beaten earnings estimates?
Corbus Pharmaceuticals Holding has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -18.6% over the last 4 quarters.
How does CRBP stock react to earnings?
CRBP stock has moved an average of +15.8% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.